This graph diagrams utilization, unit cost, and cost as a percent of overall medical cost trend: note that by the middle of 2023, GLP-1 drug costs for Group health plan members comprised 13.6% of a major pharmacy benefit management (PBM) company, shown in the third bar
That creates a feedback loop: Better appetite control improves adherence Better adherence improves outcomes Better outcomes increase motivation to continue When you see lower persistence, that does not automatically mean the drug failed
" Some patients with stable hypothyroidism may be candidates for GLP-1 therapy after a licensed provider reviews their medical history, lab results, medications, and contraindications
It targets both the dermis and subdermal layers to lift, tighten, and smooth
they're easy traps for even experienced researchers to fall into during a busy day
Recent head-to-head studies suggest that Mounjaro may offer even greater average weight loss compared to Ozempic at higher doses